| Serial Number | 79228430 |
| Word Mark | NICTUR |
| Filing Date | Friday, November 10, 2017 |
| Status | 709 - CANCELLED - SECTION 71 |
| Status Date | Friday, August 15, 2025 |
| Registration Number | 5663531 |
| Registration Date | Tuesday, January 29, 2019 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 13, 2018 |
| Goods and Services | Pharmaceutical preparations for human use for treating nighttime or daytime enuresis, primary nocturnal enuresis, nocturia, Von Willebrand-Jurgens disease, hemorrhaging, bleeding in patients with Hemophilia A, postoperative bleeding and diabetes insipidus, for the management of surgical hemostasis, for use in renal concentrating capacity test, for use in oncology, for treating cancer, for treating cardiovascular diseases, for use as antivirals, for treating inflammatory diseases and disorders of the intestine, for treating inflammatory diseases and disorders of the connective tissue, for treating arthritis, for treating urological diseases and disorders, for treating hormonal diseases and disorders, for treating endocrinological diseases and disorders, for treating psychiatric diseases and disorders, in particular mood disorders, anxiety disorders, cognitive disorders and schizophrenia, for treating neurological and neurodegenerative diseases and disorders, in particular, dementia linked to Alzheimer's disease, Huntington's disease, Parkinson's disease, cerebral palsy, brain injuries and diseases, injuries and diseases of the spinal cord, convulsive disorders, epilepsy, encephalitis, disorders of the central nervous system, ocular motility disorders, dystonia, blepharospasm, strabismus, facial scoliosis and tics, cerebral ischemia, dementia, amyotrophic sclerosis, and lateral multiple sclerosis, for treating auto-immune diseases and disorders, for treating transplant rejection, for treating ophthalmological diseases and disorders such as proliferative or non-proliferative diabetic retinopathy, macular degeneration, age-related macular degeneration, retinal neovascularization, neovascularization associated with choroidal melanoma, retinopathy, central retinal vein occlusion, pigmentary retinitis, uveitis, macular edema and cystoid macular edema; synthetic peptides for the treatment of urological, endocrine and blood diseases and disorders |
| Translation of Words in Mark | The wording "NICTUR" has no meaning in a foreign language. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Saturday, August 16, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | GP PHARM, S.A. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 85 - NOT AVAILABLE |
| Address | SantQuinti de Mediona (Barcelona) E-08777 ES |
| Party Name | GP PHARM, S.A. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 85 - NOT AVAILABLE |
| Address | SantQuinti de Mediona (Barcelona) E-08777 ES |
| Party Name | GP PHARM, S.A. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 85 - NOT AVAILABLE |
| Address | SantQuinti de Mediona (Barcelona) E-08777 ES |
| Event Date | Event Description |
| Monday, March 12, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, March 8, 2018 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB |
| Friday, March 9, 2018 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Monday, March 12, 2018 | ASSIGNED TO EXAMINER |
| Tuesday, March 13, 2018 | NON-FINAL ACTION WRITTEN |
| Wednesday, March 14, 2018 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, March 16, 2018 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, March 20, 2018 | REFUSAL PROCESSED BY MPU |
| Tuesday, March 20, 2018 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, April 13, 2018 | REFUSAL PROCESSED BY IB |
| Wednesday, September 19, 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, September 19, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, September 20, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, September 24, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, October 24, 2018 | NOTICE OF PUBLICATION |
| Wednesday, October 24, 2018 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, October 24, 2018 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Tuesday, November 13, 2018 | PUBLISHED FOR OPPOSITION |
| Friday, November 23, 2018 | NOTIFICATION PROCESSED BY IB |
| Tuesday, January 29, 2019 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, April 25, 2019 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, April 25, 2019 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, April 29, 2019 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, May 21, 2019 | FINAL DISPOSITION PROCESSED |
| Wednesday, May 22, 2019 | FINAL DISPOSITION NOTICE SENT TO IB |
| Friday, June 7, 2019 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Monday, October 19, 2020 | INTERNATIONAL REGISTRATION RENEWED |
| Monday, January 29, 2024 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Friday, August 15, 2025 | CANCELLED SECTION 71 |